Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy

Objective To evaluate the clinical efficacy and safety of leflunomide (LEF) combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy (PMN) and changes in anti-PLA2R antibody titers after treatment. Methods Sixty patients with nephrotic syndrome, biopsy-proven MN...

Full description

Bibliographic Details
Main Authors: Yaling Guo, Xueping Wu, Lei Liu, Haifeng Zhang, Lijuan Yang, Weidong Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Renal Failure
Subjects:
pla2r
primary membranous nephropathy
prednisone
leflunomide
cyclophosphamide
Online Access:http://dx.doi.org/10.1080/0886022X.2020.1713806

Internet

http://dx.doi.org/10.1080/0886022X.2020.1713806

Similar Items